Archive for the ‘Cholesterol’ Category

VAP Test Helps Researchers Uncover Best Cholesterol Lowering Treatment For Type II Diabetes

Wednesday, March 26th, 2008

The VAP cholesterol test from Atherotech is helping physicians pinpoint the most effective cholesterol and heart disease risk lowering treatments in Type II diabetes patients, providing valuable and potentially lifesaving information to diabetics and the doctors who treat them. Leveraging the expanded cholesterol profiling capabilities of ...

Cholesterol-Associated Gene Variants Can Predict Cardiovascular Events

Friday, March 21st, 2008

A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death. Led by researchers from the Massachusetts General Hospital Cardiology ...

Study Links Protein To Risk Of Heart Disease

Tuesday, March 18th, 2008

A new study published in the Journal of the American MedicalAssociation reports that there is an association between thegene for the HDL-associated protein paraoxonase 1 (PON1) and adversecardiac events such as coronary artery disease.Researcher Stanley L. Hazen, M.D., Ph.D (Cleveland Clinic) andcolleagues also find that variations in both the PON1 ...

The Genes That Protect Against Atherosclerosis, A Major Cause Of Myocardial Infarction And Stroke

Monday, March 17th, 2008

Myocardial infarction and stroke cause nearly half of all deaths in the Western World, and atherosclerosis is the main cause of myocardial infarction and stroke. Scientists from the Karolinska Institutet, Sweden, have shown with mouse models that the accumulation of the plaque that causes myocardial infarction and stroke can ...

Cholesterol-Lowering Power Of Dietitian Visits

Monday, March 17th, 2008

Worried about your cholesterol? You may want to schedule a few appointments with a registered dietitian, to get some sound advice about how to shape up your eating habits, according to a new national study led by University of Michigan Health System researchers.Not only are you likely to lower your ...

Highly Involved Patients Don’t Always See Better Health Outcomes

Monday, March 17th, 2008

Patients who prefer to be highly involved in their treatment don't necessarily have better luck managing chronic health conditions, a new study suggests.A research team based at the Veterans Affairs (VA) Iowa City Health Care System and the University of Iowa surveyed 189 veterans with high blood pressure to determine ...

New Strategy Cracks Staph Bacterium’s “Golden Armor,” Making It Vulnerable To Treatment

Monday, March 17th, 2008

Researchers have exploited a structural vulnerability in the "superbug" Staphylococcus aureus that in laboratory experiments and a mouse study opened the bacterium to treatment with an anti-cholesterol medication. This follows the 2007 discovery that a pigment provides a "golden armor" that enables staph to evade the immune system. An article ...

Bad Gene, Not Cupid, Puts Arrow Through Some Smokers’ Hearts

Monday, March 17th, 2008

The proverbial cigarette after a Valentine's Day snuggle can prematurely end a love affair, as new evidence emerges that a common defect in a gene significantly increases a smoker's risk of an early heart attack. Researchers say that as much as 60 to 70 percent of the population has ...

Genes That Protect Against Atherosclerosis Identified

Friday, March 14th, 2008

One way of combating atherosclerosis is to reduce levels of "bad cholesterol" in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring about this beneficial effect. In a new study on mice, which is presented in the open-access journal PLoS Genetics, ...

New Healthcare Marketing Vehicle Launches To Help Americans Living With Cholesterol, Diabetes And Obesity

Thursday, March 13th, 2008

HealthScreenDirect, a corporate wellness and direct-to-consumer health screening services company, announced today the launch of HealthPaks. This innovative cooperative advertising and marketing vehicle will feature exclusive health related products and services targeted to Americans living with high cholesterol, diabetes and obesity. Currently, there are more than 100 million Americans with ...

Atherosclerosis Treatment May Benefit From New Potential Drug Target

Wednesday, March 5th, 2008

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public ...

We Are What We Eat: Lowering Cholesterol The Old-Fashioned Way

Wednesday, February 27th, 2008

Recent results from a small clinical trial raised confusing questions about the value of several widely used cholesterol medicines such as Zetia and its sister drug, Vytorin. The future of these drugs now depend on three large clinical trials that may show conclusively if the drugs reduce heart attacks and ...

Understanding Atherosclerosis

Friday, February 22nd, 2008

It's the leading cause of heart disease and stroke: atherosclerosis--a disease characterized by the thickening of arterial walls, restricting blood flow like a narrow pipe. Preventing and reversing this disease is still largely a puzzle to scientists working to put all the right pieces into place and form a complete ...

Abbott Receives FDA Approval For SIMCOR® (Niaspan® / Simvastatin), A Novel Combination Medicine For Comprehensive Cholesterol Management

Monday, February 18th, 2008

Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCOR®, the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan® (Abbott's proprietary niacin extended-release) and simvastatin. SIMCOR is approved for use along with diet to lower levels of elevated total cholesterol, LDL "bad" cholesterol and triglycerides, and to ...

Abbott Receives FDA Approval For SIMCOR(R) (Niaspan(R) / Simvastatin), A Novel Combination Medicine For Comprehensive Cholesterol Management

Saturday, February 16th, 2008

Abbott received U.S. Food and Drug Administration (FDA) approval for SIMCOR(R), the first fixed-dose combination of two widely prescribed cholesterol therapies, Niaspan(R) (Abbott's proprietary niacin extended-release) and simvastatin. SIMCOR is approved for use along with diet to lower levels of elevated total cholesterol, LDL "bad" cholesterol and triglycerides, and to ...